Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jan 15, 2023; 15(1): 19-35
Published online Jan 15, 2023. doi: 10.4251/wjgo.v15.i1.19
Published online Jan 15, 2023. doi: 10.4251/wjgo.v15.i1.19
Compound or Chinese herbal medicine or formula | Cell line/animal | Molecular mechanism | Effect | Ref. |
Antrodia cinnamomea | Hep G2 | ↓CD133+ | ↓CSC | Su et al[89] |
Tiliroside | Hep3B, SNU-449 | ↓CD133+. ↓Carbonic anhydrases XII. ↑E2F1/E2F3/Caspase-3 axis | ↓Tumor sphere formation. ↓WInvasion and migration. ↓Stemness gene expression. ↑Apoptosis | Han et al[90] |
8-bromo-7-methoxychrysin | SMMC-7721, MHCC97H-derived LCSLCs | ↓CD133, CD44. ↓IL-6 | ↓CSC | Wen et al[91] |
Curcumin | PLC/PRF5, WRL68, Huh7, KMCH, AFP-negative primary HCC cell line | ↓CD117, EpCAM, CD133, RNF51, NANOG. ↓NF-κB | ↓CSC | Marquardt et al[92] |
Sophocarpine | HCC-LM3, MHCC-97H. BALB/c nude mice (4-wk, male, 0.4-6 g/kg, twice a week for 4 wk) | ↓TGF-β. ↓CD133, CD90 and EpCAM | ↓EMT. ↓CSC | Zhang et al[93] |
Matrine | Hep3B, Huh7. BALB/c nude mice (-,-,10 mg/kg, daily for 3 wk) | ↓EpCAM+/CD133+ cell number. ↓PI3K/AKT/mTOR pathway, AKT/GSK-3β/β-catenin pathway | ↓Sphere formation. ↓Stem cell markers. ↑Mature hepatocyte markers | Liu et al[94] |
Brucea javanica | HepG2 (HB-8065, wild-type p53), Hep3B (HB-8064, p53-null) | ↓CD133, NANOG, EpCAM | ↑Apoptosis. ↓Stem-like cells | Chen et al[95] |
2-Ethoxystypandrone | Hep3B, HepG2, Huh7, Li-7, SK-Hep-1 | ↓STAT3 activation | ↓Proliferation, ↑Apoptosis. ↓CSC | Li et al[96] |
BRM270 | HepG2 (CD133+), SNU-398. CRJORI:CD-1-5WM (6-wk, male, 5 mg/kg/day, daily for 12 wk) | ↓CyclinD1/Bcl2 mediated c-Jun apoptotic pathway. ↓CD113 | ↓Proliferation, ↑Apoptosis. ↓CSC | Kumar et al[97] |
Songyou Yin (consisted by Salvia miltiorrhiza, Astragalus membranaceus, Lycium barbarum, Crataegus pinnatifida and Trionyx sinensis) | MHCC97-H, Hep3B | ↓CD90, BCRP, ALDH, CD44, EpCAM, vimentin, MMP-9. ↑E-cadherin | ↑Oxaliplatin chemosensitivity. ↓Motility, invasion, and colony formation. ↓CSC | Jia et al[98] |
- Citation: Lai HC, Lin HJ, Jeng LB, Huang ST. Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(1): 19-35
- URL: https://www.wjgnet.com/1948-5204/full/v15/i1/19.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i1.19